News
Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission after stopping Tasigna
In ENESTfreedom, 51.6% of eligible first-line Tasigna patients maintained TFR for 48 weeks after stopping treatment; study did not meet its statistical primary...
Press Releases
AstraZeneca,Ironwood enter U.S. licensing agreement for lesinurad
AstraZeneca announced that it has completed the licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic (lesinurad) and the fixed-dose combination...
Press Releases
Shire Plc completes combination with Baxalta Inc creating global biotech leader in rare diseases
Shire plc completed its previously announced combination with Baxalta Incorporated ,creating the leading global biotechnology company focused on serving patients with rare diseases and...
Press Releases
EU approves Novartis drug Afinitor to treat certain types of advanced GI and lung NET
Novartis announced that the EU has approved Afinitor®(everolimus) tablets for the treatment of unresectable or metastatic, well-differentiated (Grade 1 or Grade 2) nonfunctional neuroendocrine...
News
AbbVies Research Commitment to Helping People Living with Rheumatologic Diseases Highlighted Annual EULAR 2016
AbbVie a global biopharmaceutical company announced that data on HUMIRA® (adalimumab), investigational medicines and research, including real-world evidence, aiming to improve clinical outcomes for...
Press Releases
Peregrine Pharmaceuticals Updates Highlighting Latest Developments for Contract Manufacturing and Drug Development Businesses
Contract Manufacturing Revenue Hits All-Time High of $44 Million for Fiscal Year Ended April 2016; Fiscal Year 2017 Contract Manufacturing Revenue Projected Between $50-55...
News
PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from The American Business Awards
PAREXEL International Corporation ,a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read